Singh, C., Valero, D. J., Nisar, J., Trujillo Ramirez, J. I., Kothari, K. K., Isola, S., . . . Gordon, D. K. (2020). Statins Versus Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors- Are We Doing Better? A Systematic Review on Treatment Disparity. Cureus.
Citação norma ChicagoSingh, Chetana, Danel J. Valero, Javariya Nisar, Jose I. Trujillo Ramirez, Karisma K. Kothari, Sasank Isola, Aleyda M. San Hernandez, and Domonick K. Gordon. "Statins Versus Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors- Are We Doing Better? A Systematic Review On Treatment Disparity." Cureus 2020.
MLA citiranjeSingh, Chetana, et al. "Statins Versus Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors- Are We Doing Better? A Systematic Review On Treatment Disparity." Cureus 2020.